Evidence map›Paper›PMID 31516136›Full record

ArticleIndian journal of dermatology

A Study of

Shital Poojary, Autar Miskeen, Jimish Bagadia, Saurabh Jaiswal, Priya Uppuluri

Open access · diamondAbstract read
In one paragraph

Article in Indian journal of dermatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Evaluation of Antifungal Activity AgainstHIV/AIDS (Auckland, N.Z.) · 2025
    Article
  3. Article
  4. Article
  5. Pathogenesis, Immunology and Management of Dermatophytosis.Journal of fungi (Basel, Switzerland) · 2021
    Review
  6. Article
  7. Population differentiation, antifungal susceptibility, and host range of Trichophyton mentagrophytes isolates causing recalcitrant infections in humans and animals.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Shital PoojaryDepartment of Dermatology and Venereology, K. J. Somaiya Hospital and Research Centre, Mumbai, Maharashtra, India.
Autar MiskeenDR Miskeen's Central Clinical Microbiology Laboratory, Thane, Maharashtra, India.
Jimish BagadiaDepartment of Dermatology and Venereology, K. J. Somaiya Hospital and Research Centre, Mumbai, Maharashtra, India.
Saurabh JaiswalDepartment of Dermatology and Venereology, K. J. Somaiya Hospital and Research Centre, Mumbai, Maharashtra, India.
Priya UppuluriDavid Geffen School of Medicine at UCLA Division of Infectious Diseases, Harbor-UCLA Medical Center, USA.
K. J. Somaiya Hospital & Research Centre · INHarbor–UCLA Medical Center · US

Funding

Development of Immunotherapeutic Strategies to Overcome Neonatal CandidiasisR21HD097480 · NICHD · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI UPPULURI, PRIYA · 2019 to 2020
$446k
NICHD NIH HHS R21 HD097480
6 · The paper itself

Abstract

backgroundRecent years have seen an alarming rise in the prevalence of recalcitrant and relapsing dermatophyte infections in India associated with lack of clinical response to standard antifungal regimens. AIMS AND

objectivesA study was undertaken to identify the antifungal susceptibility patterns of dermatophyte species isolated from lesions of dermatophytoses in patients examined at our center. MATERIALS AND

methodsA total of 85 patients with clinically diagnosed dermatophytoses were subjected to skin scrapings for potassium hydroxide mount (microscopic examination) and culture using Sabouraud's agar medium containing chloramphenicol and cycloheximide (incubated at 30°C). Antifungal susceptibilities [minimum inhibitory concentration-90 (MIC-90)] of the identified dermatophytes were tested for seven systemic and topical antifungal agents (terbinafine, griseofulvin, itraconazole, fluconazole, sertaconazole, ketoconazole, and clotrimazole) using Clinical and Laboratory Standards Institute broth microdilution method (M38-A).

results

conclusionsThis study indicates a rising proportion of

Indexed as

Antifungal susceptibilitydermatophytesminimum inhibitory concentration

Identifiers

PMID31516136
PMCPMC6714203
OpenAlexW2955420445

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.